Scarica l'app Stockscreener
104.87
1.04%
1.08
Dopo l'orario di chiusura:
104.24
-0.63
-0.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$103.79
Aprire:
$104.85
Volume 24 ore:
6.16M
Relative Volume:
1.12
Capitalizzazione di mercato:
$153.75B
Reddito:
$16.75B
Utile/perdita netta:
$1.85B
Rapporto P/E:
83.90
EPS:
1.25
Flusso di cassa netto:
$2.37B
1 W Prestazione:
+0.46%
1M Prestazione:
+1.75%
6M Prestazione:
+29.25%
1 anno Prestazione:
+56.22%
Intervallo 1D:
$103.83
$105.57
Intervallo di 1 settimana:
$97.08
$105.57
Portata 52W:
$65.52
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Confronta BSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
104.87 | 153.75B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
140.22 | 241.69B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
394.88 | 150.24B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
94.30 | 120.56B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.39 | 42.42B | 5.72B | 4.17B | 490.10M | 6.97 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Beyond The Numbers: 17 Analysts Discuss Boston Scientific Stock - Benzinga
Boston Scientific makes second acquisition for $360M upfront - The Business Journals
Boston Scientific To Acquire SoniVie For $400 Million, Expanding Hypertension Treatment Portfolio - Benzinga
Boston Scientific to Purchase SoniVie Ltd. - MPO-mag
Boston Scientific to acquire renal denervation company SoniVie - Mass Device
Boston Scientific Announces Agreement To Acquire Sonivie Ltd -March 03, 2025 at 08:55 am EST - Marketscreener.com
Boston Scientific To Buy SoniVie For Upfront Payment Of Approx. $360 Mln - Nasdaq
Boston Scientific announces agreement to acquire SoniVie Ltd. - Quantisnow
The Zacks Analyst Blog The Goldman Sachs, The Progressive, Boston Scientific and Cooper-Standard - Zacks Investment Research
Cavalier Investments LLC Raises Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Bank of New York Mellon Corp Has $1.11 Billion Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Top Stock Reports for Goldman Sachs, Progressive & Boston Scientific - Yahoo Finance
Boston Scientific Stock Price | BSX Stock Quote, News, and History - Markets Insider
Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 4,675 Shares of Stock - MarketBeat
Consilium Wealth Advisory LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
April 11th Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific Corporation (BSX): Among Stocks to Invest In from Israel Englander’s Portfolio - Insider Monkey
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Alecta Tjanstepension Omsesidigt - MarketBeat
New York Life Investment Management LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Fisher Funds Management LTD Buys New Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Stake Raised by HealthInvest Partners AB - MarketBeat
Boston Scientific Announces Completion Of EUR1.5 Billion Offering Of Senior Notes - Marketscreener.com
Boston Scientific announces completion of €1.5 billion offering of senior notes - Quantisnow
Catheter Market Global Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, BD and Co, Boston Scientific, Teleflex, Medtronic, Johnson & Johnson, Edwards Lifesciences, Stryker - Yahoo Finance
Atria Wealth Solutions Inc. Boosts Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific’s SWOT analysis: innovative medtech stock poised for growth - Investing.com
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today - Benzinga
Boston Scientific Recalls Accolade Pacemaker Devices - The Rochester Sentinel
Boston Scientific reports first cases with next-gen Faraflex catheter - Mass Device
Boston Scientific Co. (NYSE:BSX) Stock Position Lessened by Bradley Foster & Sargent Inc. CT - MarketBeat
Boston Scientific director Zane Ellen M sells $1.42 million in stock By Investing.com - Investing.com South Africa
StockNews.com Downgrades Boston Scientific (NYSE:BSX) to Hold - MarketBeat
Boston Scientific director Zane Ellen M sells $1.42 million in stock - Investing.com India
Boston Scientific Director Sells Over $1.4 Million in Company Stock - TradingView
Boston Scientific Loses Patent For Flexible Stent On Appeal - Law360
Boston Scientific prices $1.6B public offering - Mass Device
Balloon Catheters Patent Landscape Report 2025, with - GlobeNewswire
Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System - Yahoo Finance
What Does the Market Think About Boston Scientific? - Benzinga
Truist Financial Corp Sells 4,801 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's SVP Vance Brown sells $504,992 in stock By Investing.com - Investing.com Australia
TKG Advisors LLC Boosts Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Announces Pricing Of EUR1.5 Billion Of Senior Notes -February 22, 2025 at 03:16 am EST - Marketscreener.com
Boston Scientific Co. (NYSE:BSX) Shares Sold by New York State Common Retirement Fund - MarketBeat
Boston Scientific announces pricing of €1.5 billion of senior notes - The Malaysian Reserve
Boston Scientific's American Medical Systems Europe Prices EUR 1.5 Bln Of Senior Notes - Nasdaq
Boston Scientific raises €1.5bn after double upgrade - GlobalCapital
Boston Scientific's SVP Vance Brown sells $504,992 in stock - Investing.com India
Boston Scientific’s SVP Vance Brown sells $504,992 in stock By Investing.com - Investing.com Nigeria
BSX: 3 Medical Device Stocks Seeing Surge in Demand - StockNews.com
FDA Boston Scientific Corporation Recalls Accolade Pacemaker Devices Due To Manufacturing Issue That May Lead To Early Device Replacement - Marketscreener.com
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.25%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):